A safety review of a key abortion medication is ongoing. This process has been met with criticism from those who oppose abortion, as they had hoped for a different outcome. The review's timeline has been extended into next year.

The medication in question was initially approved over two decades ago. Since then, its safety and effectiveness have been reaffirmed multiple times.

Further information about this review and its progress can be found through official updates and related stories, which provide more details on the situation and the medication's history.